UNSPSC 51263133: Penbutolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 78W62V43DY. European Medicines Agency schedules Penbutolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09660MIG. Penbutolol generally arises in the molecular formula C18H29NO2.

UNSPSC 51263133 Penbutolol is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent opportunity record shows a mismatch between the code's nominal scope and actual buying activity. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026, was tagged to this code but sought Naloxone and drug deactivation systems rather than penbutolol—an opioid antagonist and harm-reduction equipment, not a beta-blocker pharmaceutical. The procurement pattern suggests that state and local governments tag health-related goods to available pharmaceutical codes without strict adherence to drug specificity, meaning vendors pursuing this code should expect public-health agencies (counties, municipalities, and special districts) to use it for a broader range of emergency medical supplies and community health initiatives beyond the individual drug name.

Seminole County's procurement reflects the geographic and operational reality: Florida counties with active public health infrastructure use these codes to source materials for overdose response and drug diversion programs. The IFB required 1,900 units of Naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and closed July 26, 2023. Vendors faced standard state and local requirements—E-Verify compliance, drug-free workplace certification, commercial general liability and workers' compensation insurance, and a three-month probationary period—with potential FEMA funding introducing federal compliance overlays (Clean Air Act, Federal Water Pollution Control Act). The contract carried a two-year initial term with one-year renewal option and was awarded on a fixed-fee basis. Recent activity under this code is sparse; the single posted opportunity and the code-to-scope mismatch signal that this Commodity code may see limited, inconsistent use for state and local pharmaceutical and medical-supply procurement.